Forecast & Rating4 analysts currently cover Catalyst Pharma, of which 0 give a positive rating. The average price target is $31.67, about 0.6% upside from the current price of $31.49. Coverage is limited, so the data is for reference only. Data as of Jun 12, 2026; this does not constitute investment advice.
Jun 12, 2026
Price forecast
$31.670.56%
Forecast & RatingHold
4analysts
Strong buy0.00%
Buy0.00%
Hold100.00%
Sell0.00%
Strong sell0.00%
Strong buy
0
Buy
0
Hold
4
Sell
0
Strong sell
0
Target price forecast
Forecast baselineJul 12, 2026
Forecast met44.7%
Stock price$31.48
Average forecast price$34.9
Highest forecast price$40
Lowest forecast price$32
Average forecast price
$34.9
Highest forecast price
$40
Lowest forecast price
$32
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.